ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Genentech/Pieris Pact Follows Abandoned
ScripAstraZeneca PLC ’s hopes of emulating Amarin Corp. PLC ’s Vascepa with its omega-3 product Epanova have been hit just as commercial prospects were put on hold for Acasti Pharma Inc. 's similar produ
ScripThe progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
ScripChina’s healthcare industry has seen an increased level of financing activity in November, with a total of 24 deals in mostly early stage fundraisings for precision medicine and cell therapy. Among th